Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
Baylor College of Medicine · Texas Children's Hospital · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
184
total citations
- FWCI
- 39.88
- Percentile
- 100%
- References
- 58
Citations per year
Authors
28Topics & keywords
Topics
Keywords
- Medicine
- Chimeric antigen receptor
- Natural killer T cell
- Immunology
- Immune system
- Refractory (planetary science)
- Cytokine
- Neuroblastoma
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.